LEADING THE FIGHT AGAINST BLINDING EYE DISEASES


LEITR’s new model will fill a pressing need by providing normal and diseased human eye tissue to advance our understanding of biochemical, cellular, and molecular events that lead to blindness— with the ultimate goal of improving outcomes and enhancing quality of life for people who are blind or visually impaired. This new research model is important because it creates a single site that not only collects human eye tissue but provides on-site capabilities.